Boehringer Ingelheim Leads The Way In Social Media Says Report
by Pharmacy Life - Published on 03 May 2015
The pharmaceutical industry is becoming increasingly reliant on social media as a key platform for communicating with multiple stakeholders. But who exactly are the big players?
That's what
Ogilvy Healthworld wanted to find out, so the company carried out a major study of the big pharma players and assessed
how each company was performing across six key categories including: the number of social networks they were present on, the freshness of their content and their engagement with their users.
The results of Ogilvy Healthworld's research has now been released in a new report,
'Connecting the dots: Which Pharma Companies are Succeeding in the Social Media Space?', the first of its kind to provide insights into the social media marketing strategies of the major pharma companies.
The results provided some very interesting statistics!
According to the report,
Boehringer Ingelheim, which was the first pharma firm to totally engage with social media, was highlighted as the
market leader as regards digital health. Ogilvy Healthworld also felt that
Bayer, Novartis, J&J and Merck had performed well, but pointed out that other companies such as GSK, Roche, Lilly, Sanofi, AZ and Pfizer needed to pull their socks up!
According to the report, the average number of
pharma tweets has increased by 530 per cent since 2013, with
Twitter followers increasing by almost 300 per cent.
For more on the report click here.